GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SOFIVA GENOMICS Co Ltd (ROCO:6615) » Definitions » 3-Year EPS without NRI Growth Rate

SOFIVA GENOMICS Co (ROCO:6615) 3-Year EPS without NRI Growth Rate : -31.80% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is SOFIVA GENOMICS Co 3-Year EPS without NRI Growth Rate?

SOFIVA GENOMICS Co's EPS without NRI for the three months ended in Dec. 2024 was NT$-0.25.

During the past 12 months, SOFIVA GENOMICS Co's average EPS without NRI Growth Rate was 57.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was -31.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was -24.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was -9.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 12 years, the highest 3-Year average EPS without NRI Growth Rate of SOFIVA GENOMICS Co was 11.40% per year. The lowest was -31.80% per year. And the median was -9.35% per year.


Competitive Comparison of SOFIVA GENOMICS Co's 3-Year EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, SOFIVA GENOMICS Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SOFIVA GENOMICS Co's 3-Year EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SOFIVA GENOMICS Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where SOFIVA GENOMICS Co's 3-Year EPS without NRI Growth Rate falls into.


;
;

SOFIVA GENOMICS Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


SOFIVA GENOMICS Co  (ROCO:6615) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


SOFIVA GENOMICS Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of SOFIVA GENOMICS Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


SOFIVA GENOMICS Co Business Description

Traded in Other Exchanges
N/A
Address
No. 66-1, Sec. 1, Chongqing S. Road, 4th Floor, Zhongzheng District, Taipei, TWN, 10043
SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, pre-natal and neonatal genetic testing and medical testing and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.

SOFIVA GENOMICS Co Headlines

No Headlines